Immunology and Oncology at the Tübingen site
Cluster of Excellence
Cluster of Excellence iFIT- Image-Guided and Functionally Instructed Tumor Therapies
The Cluster of Excellence "Image-Guided and Functionally Instructed Tumor Therapies (iFIT)" aims to achieve a comprehensive understanding of biological processes in tumors in order to develop innovative and sustainable cancer therapies.Learn more
German centres of health research
German Consortium for Translational Cancer Research (DKTK)
In the German Consortium for Translational Cancer Research, researchers and doctors at eight locations in Germany are cooperating in order to bring promising approaches in cancer research into clinical practice more quickly.
SFB/TR 156 - The skin as sensor and initiator of local and systemic immune reactions
The aim of the SFB is to understand skin immunity in its complexity in order to provide a basis for therapeutic interventions.
SFB/TR 209 - Liver cancer
Liver cancer is the fifth most common tumor disease worldwide, with one of the highest mortality rates among all cancers. However, it is not yet known how liver cancer develops from the known risk factors - liver infection, liver cirrhosis or even metabolic diseases. The Collaborative Research Centre/Transregional Collaborative Research Centre "Liver cancer - new mechanistic and therapeutic concepts in a solid tumour model" aims to close these gaps in knowledge by combining basic research and clinical subprojects.
FOR 2314: Solid tumours - Therapeutic Windows
The goal of the DFG Research Group FOR 2314 is to identify vital cellular processes in tumor cells in collaboration with researchers from the University of Würzburg, which can be used for an innovative therapy.
FOR 2060: cGMP Signalling in Cell Growth and Survival
The unifying goal of the research group is to investigate how cGMP affects the remodeling, degeneration and regeneration of tissues in the cardiovascular, nervous and neurosensory systems.
Comprehensive Cancer CenterTübingen-Stuttgart - CCC
The German Cancer Aid supports the Southwest German Tumor Center at the University Hospital Tübingen.
In total, the German Cancer Aid supports 11 top oncological centers nationwide.
EU / ERC Grants
in vivo analysis of cholangiocarcinoma development, progression and metastasis
Prof. Dr. Lars ZenderMedical
Innovative cancer management: First in human senescence imaging
Prof. Dr. Bernd PichlerPreclinical
imaging and radiopharmacy
The Department of Peptide-based Immunotherapy headed by Prof. Juliane Walz researches and develops T-cell-based immunotherapies for infectious and tumor diseases.To the website